IEQ Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Sell |
3,913
-4,306
| -52% | -$2.26M | 0.01% | 634 |
|
|
2025
Q1 | $5.21M | Buy |
8,219
+4,381
| +114% | +$2.78M | 0.04% | 332 |
|
|
2024
Q4 | $2.73M | Sell |
3,838
-1,496
| -28% | -$1.07M | 0.03% | 422 |
|
|
2024
Q3 | $5.61M | Sell |
5,334
-197
| -4% | -$207K | 0.07% | 183 |
|
|
2024
Q2 | $5.81M | Buy |
5,531
+507
| +10% | +$533K | 0.08% | 164 |
|
|
2024
Q1 | $4.84M | Buy |
5,024
+585
| +13% | +$563K | 0.07% | 185 |
|
|
2023
Q4 | $3.9M | Buy |
4,439
+990
| +29% | +$870K | 0.06% | 188 |
|
|
2023
Q3 | $2.84M | Buy |
3,449
+103
| +3% | +$84.8K | 0.06% | 201 |
|
|
2023
Q2 | $2.4M | Buy |
3,346
+73
| +2% | +$52.5K | 0.05% | 235 |
|
|
2023
Q1 | $2.69M | Sell |
3,273
-299
| -8% | -$246K | 0.06% | 205 |
|
|
2022
Q4 | $2.58M | Buy |
3,572
+336
| +10% | +$242K | 0.07% | 198 |
|
|
2022
Q3 | $2.23M | Buy |
3,236
+744
| +30% | +$512K | 0.06% | 213 |
|
|
2022
Q2 | $1.47M | Buy |
2,492
+324
| +15% | +$192K | 0.04% | 246 |
|
|
2022
Q1 | $1.51M | Buy |
2,168
+407
| +23% | +$284K | 0.04% | 255 |
|
|
2021
Q4 | $1.11M | Sell |
1,761
-63
| -3% | -$39.8K | 0.03% | 285 |
|
|
2021
Q3 | $1.1M | Buy |
1,824
+819
| +81% | +$496K | 0.03% | 281 |
|
|
2021
Q2 | $561K | Buy |
1,005
+427
| +74% | +$238K | 0.02% | 342 |
|
|
2021
Q1 | $273K | Buy |
+578
| New | +$273K | 0.01% | 383 |
|
|
2020
Q4 | – | Sell |
-767
| Closed | -$429K | – | 354 |
|
|
2020
Q3 | $429K | Buy |
767
+1
| +0.1% | +$559 | 0.02% | 252 |
|
|
2020
Q2 | $478K | Hold |
766
| – | – | 0.03% | 204 |
|
|
2020
Q1 | $373K | Buy |
766
+94
| +14% | +$45.8K | 0.03% | 244 |
|
|
2019
Q4 | $253K | Buy |
+672
| New | +$253K | 0.02% | 345 |
|